India Electrotherapy Market

ID: MRFR/Pharma/51196-HCR 200 Pages Satyendra Maurya Last Updated: September 17, 2026
India Electrotherapy Market Research Report By Treatment Type (Extracorporeal Shock Wave Therapy, Interferential Current Therapy (IC), Magnetic Field Therapy, Ultrasound Therapy, Transcutaneous Electrical Nerve Stimulation (TENS) Therapy, Micro-Current Therapy), By Device Type (Transcutaneous Electrical Neural Stimulation (TENS), Electronic Muscle Stimulator (EMS), Interferential Stimulator (IF), High Voltage Pulsed Galvanic Stimulator (HVPGS)), By Application (Pain Management, Neuromuscular Dysfunction, Urine and Fecal Incontinence, Acute and Chronic Edema, Tissue Repair, Iontophoresis, Orthopedics, Cardiology) and By End User (Hospitals and amp; Clinics, Rehabilitation Centers, Long Term Centers) -Forecast to 2035
India Electrotherapy Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.02%
2024 Market Size$ 43.09 Million
2025 Market Size$ 44.82 Million
2035 Market Size$ 66.5 Million
Key Players
Medtronic
Boston Scientific
Abbott Laboratories
NeuroMetrix
Zynex
Nuvectra
Trends
  • Technological Advancements
  • Growing Acceptance in Rehabilitation
  • Regulatory Support for Innovation
Opportunities
  • Increased Healthcare Expenditure
  • Rising Prevalence of Chronic Pain
  • Supportive Regulatory Environment
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Treatment Type (USD Million)
      1. 4.1.1 Extracorporeal Shock Wave Therapy
      2. 4.1.2 Interferential Current Therapy
      3. 4.1.3 Magnetic Field Therapy
      4. 4.1.4 Ultrasound Therapy
      5. 4.1.5 Transcutaneous Electrical Nerve Stimulation (TENS) Therapy
      6. 4.1.6 Micro-Current Therapy
    2. 4.2 Chemicals and Materials, BY Device Type (USD Million)
      1. 4.2.1 Transcutaneous Electrical Neural Stimulator (TENS)
      2. 4.2.2 Electronic Muscle Stimulator (EMS)
      3. 4.2.3 Interferential Stimulator (IF)
      4. 4.2.4 High Voltage Pulsed Galvanic Stimulator (HVPGS)
    3. 4.3 Chemicals and Materials, BY Application (USD Million)
      1. 4.3.1 Pain Management
      2. 4.3.2 Neuromuscular Dysfunction
      3. 4.3.3 Urine and Fecal Incontinence
      4. 4.3.4 Acute and Chronic Edema
      5. 4.3.5 Tissue Repair
      6. 4.3.6 Iontophoresis
      7. 4.3.7 Orthopedics
      8. 4.3.8 Cardiology
    4. 4.4 Chemicals and Materials, BY End User (USD Million)
      1. 4.4.1 Hospitals & Clinics
      2. 4.4.2 Rehabilitation Centers
      3. 4.4.3 Long Term Care Centers
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Abbott Laboratories (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 NeuroMetrix (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Zynex (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Nuvectra (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 H-Wave (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Omron Healthcare (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Bioness (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY TREATMENT TYPE
    3. 6.3 INDIA MARKET ANALYSIS BY DEVICE TYPE
    4. 6.4 INDIA MARKET ANALYSIS BY APPLICATION
    5. 6.5 INDIA MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY TREATMENT TYPE, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Electrotherapy Market Segmentation

India Electrotherapy Market By Treatment Type (USD Million, 2025-2035)

  • Extracorporeal Shock Wave Therapy
  • Interferential Current Therapy
  • Magnetic Field Therapy
  • Ultrasound Therapy
  • Transcutaneous Electrical Nerve Stimulation (TENS) Therapy
  • Micro-Current Therapy

India Electrotherapy Market By Device Type (USD Million, 2025-2035)

  • Transcutaneous Electrical Neural Stimulator (TENS)
  • Electronic Muscle Stimulator (EMS)
  • Interferential Stimulator (IF)
  • High Voltage Pulsed Galvanic Stimulator (HVPGS)

India Electrotherapy Market By Application (USD Million, 2025-2035)

  • Pain Management
  • Neuromuscular Dysfunction
  • Urine and Fecal Incontinence
  • Acute and Chronic Edema
  • Tissue Repair
  • Iontophoresis
  • Orthopedics
  • Cardiology

India Electrotherapy Market By End User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Rehabilitation Centers
  • Long Term Care Centers

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.